Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **skin lipid barrier** refers to the specialized extracellular matrix of lipids within the outermost layer of the epidermis—the stratum corneum. This structure is composed primarily of ceramides, cholesterol, and free fatty acids arranged in highly organized lamellar layers between dead keratinocytes (corneocytes). The "brick-and-mortar" model describes corneocytes as bricks held together by this intercellular lipid mortar. The main functions are preventing excessive water loss from the body (transepidermal water loss), protecting against entry of pathogens/allergens/irritants from outside environments, maintaining hydration/homeostasis in deeper layers of skin tissue, supporting normal microbial flora on the surface ("microbiome"), and contributing indirectly to immune defense. Disruption or deficiency in these lipids leads to impaired function—manifesting clinically as dry/sensitive/inflamed skin conditions such as atopic dermatitis or eczema. Restoration strategies focus on replenishing lost lipids with topical formulations containing ceramides/cholesterol/fatty acids. Note: The "skin lipid barrier" is **not** a single molecule/receptor/enzyme/transporter but rather an essential structural feature formed by multiple molecules working together within tissue architecture. It should not be classified as a canonical therapeutic target like receptors or enzymes; instead it represents an important physiological system relevant for dermatology research and therapy development.
Drugs do not directly target the "skin lipid barrier" as a receptor or enzyme. Instead, topical agents may restore its function by replenishing key lipids like ceramides and fatty acids.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skin lipid barrier.